Chronic Granulomatous Disease: a Cohort of 173 Patients-10-Years Single Center Experience from Egypt

J Clin Immunol. 2023 Nov;43(8):1799-1811. doi: 10.1007/s10875-023-01541-4. Epub 2023 Jul 11.

Abstract

Purpose: Chronic granulomatous disease (CGD) is an inherited primary immunodeficiency disorder of phagocytes, characterized by recurrent fungal and bacterial infections. Our aim is to describe the different clinical presentations, non-infectious auto-inflammatory features, types and sites of infections, and to estimate the mortality among our large cohort.

Methods: This is a retrospective study conducted at the Pediatric Department of Cairo University Children's Hospital in Egypt, including cases with a confirmed CGD diagnosis.

Results: One hundred seventy-three confirmed CGD patients were included. AR-CGD was diagnosed in 132 patients (76.3%) including 83 patients (48%) with p47phox defect, 44 patients (25.4%) with p22phox defect, and 5 patients (2.9%) with p67phox defect. XL-CGD was diagnosed in 25 patients (14.4%). The most common recorded clinical manifestations were deep-seated abscesses and pneumonia. Gram-negative bacteria and Aspergillus were the most frequently isolated species. Regarding the outcome, 36 patients (20.8%) were lost from follow-up. Among patients with known outcome, 94/137 patients (68.6%) are living, while 43/137 patients (31.4%) died.

Conclusion: AR-CGD is predominant in Egypt; CGD must always be ruled out in any patient presenting with typical or atypical mycobacterial or BCG-disease.

Keywords: AR-CGD; Autoimmune manifestations in CGD; CGD in Egypt; Infections in CGD; X-linked CGD.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Child
  • Egypt / epidemiology
  • Granulomatous Disease, Chronic* / diagnosis
  • Granulomatous Disease, Chronic* / epidemiology
  • Granulomatous Disease, Chronic* / genetics
  • Humans
  • Nontuberculous Mycobacteria
  • Patients
  • Primary Immunodeficiency Diseases*
  • Retrospective Studies